Add BrightSurf on Google Email

Understanding the brain's 'suffocation alarm'

Research identifies ASIC1a gene variants associated with panic disorder and respiratory symptoms such as shortness of breath and feelings of suffocation. The study found that the genes are also linked to amygdala structure and function, raising hopes for new treatments.

SourceElsevier·JournalBiological Psychiatry·DateDec 1, 2014

Missing gene linked to autism

Researchers at the University of Leeds have identified a missing gene mutation linked to autistic traits in mice. The study found behavioural features similar to autism symptoms, including sociability issues and impaired neurotransmitter release.

SourceUniversity of Leeds·JournalTranslational Psychiatry·DateNov 25, 2014

Educating on sickle cell risk

Sickle cell disease carriers in sub-Saharan Africa require aggressive public health education to raise awareness of the risks of having children with the disease. The disorder causes significant physical and emotional challenges, as well as potential life-threatening complications.

SourceInderscience Publishers·JournalInternational Journal of Medical Engineering and Informatics·DateNov 24, 2014

Drug treats inherited form of intellectual disability in mice

Researchers have successfully treated a genetic form of intellectual disability in mice using an anticancer drug, suggesting a potential new approach for the human condition. The study's findings indicate that altering the balance between chromatin's open and closed states could be key to treating Mendelian disorders of the epigenetic ...

SourceJohns Hopkins Medicine·JournalScience Translational Medicine·DateOct 1, 2014

WSU researchers find crucial step in DNA repair

Scientists at Washington State University have discovered a critical step in the DNA repair process that could lead to new therapies for hereditary diseases. They found that a specific protein must be 'unbuckled' to allow easy access for the DNA repair crew, and this discovery may lead to targeted gene therapy.

SourceWashington State University·JournalProceedings of the National Academy of Sciences·DateAug 18, 2014

Hereditary disease genes found throughout the human body

A study published in PLOS Computational Biology reveals that hereditary disease genes are found throughout the human body. This discovery highlights tissue-specific protein interactions and provides a powerful tool for identifying new therapeutic targets.

SourcePLOS·JournalPLOS Computational Biology·DateJun 12, 2014

Pioneer Award recipients Marina Cavazzana and Adrian Thrasher recognized for advancing gene therapy to the clinic for immunodeficiency disorders

Marina Cavazzana and Adrian Thrasher have been honored with the Pioneer Award for basic and clinical gene therapy for immunodeficiency disorders. They are pioneers in treating life-threatening inherited diseases of the immune system with gene therapy, using a patient's own modified stem cells.

New gene for bipolar disorder discovered

A recent study published in Nature Communications has identified two new gene regions linked to bipolar disorder, bringing hope for new treatments. The research, involving over 24,000 patients and healthy individuals, sheds light on the genetic factors contributing to the complex condition.

SourceUniversity of Basel·JournalNature Communications·DateMar 11, 2014

New gene for bipolar disorder discovered

Researchers identified two new gene regions associated with bipolar disorder and confirmed three existing ones through a massive international collaboration. The study analyzed genetic data from over 9,400 patients and found that these genes work together with environmental factors to contribute to the disease.

SourceUniversity of Bonn·JournalNature Communications·DateMar 11, 2014

Gene therapy for lysosomal storage disease shown to be safe and well tolerated

A new gene therapy approach has been shown to be safe and well-tolerated in a clinical trial of four children with mucopolysaccharidosis type IIIA, an inherited lysosomal storage disease. The treatment involved delivering therapeutic genes via an adeno-associated viral vector, resulting in improved brain shrinkage and behavioral changes.

Study uncovers why autism is more common in males

A large cohort study found that females diagnosed with autism spectrum disorder (ASD) and other neurodevelopmental disorders have a greater number of harmful genetic mutations than males. This suggests that the female brain requires more extreme genetic alterations to produce symptoms of ASD or neurodevelopmental disorders.

SourceCell Press·JournalAmerican Journal of Human Genetics·DateFeb 27, 2014

Discovery may help to explain mystery of 'missing' genetic risk

A new study in PLOS Genetics finds common genetic variants may indicate the presence of influential rare mutations that have yet to be discovered. This 'synthetic association' sheds light on the genetic make-up's large influence on cancer risk, highlighting the importance of identifying causal genetic changes.

SourcePLOS·JournalPLOS Genetics·DateFeb 13, 2014

Does the body's immune response to viral vector delivery systems affect the safety or efficacy of gene therapy?

A recent study published in Human Gene Therapy evaluated the immune response to viral vector delivery systems and their impact on gene therapy's safety and efficacy. The researchers found that the systemic and local immune reactions induced by AAV-based gene therapy did not affect the safety of gene therapy or expression of the replace...

SourceMary Ann Liebert, Inc./Genetic Engineering News·JournalHuman Gene Therapy·DateJan 8, 2014

Mass. General study identifies genes uniquely expressed by the brain's immune cells

A new sequencing method identified a set of genes used by microglia to sense their environment, called the 'sensome'. As aging increases, microglia's expression of neuroprotective genes becomes more active while toxic actions are downregulated. This discovery may lead to better understanding and treatments for neurodegenerative disorders.

SourceMassachusetts General Hospital·JournalNature Neuroscience·DateNov 14, 2013